The inflammatory cytokines reduce the hepatic LDLR protein levels causing dyslipidemia which in turn, promotes the accumulation of fat tissues, insulin resistance, and obesity-associated inflammation (57, 58). The gene discussed is LDLR; the disease is metabolic syndrome.